PMLiVE6h
Porterhouse Medical appoints Michael Tague as president of Porterhouse Medical US
Global healthcare communications company Porterhouse Medical has announced the appointment of Michael Tague as president of ...
PMLiVE6h
FDA approves Mirum’s Ctexli as first treatment for rare lipid storage disease CTX
The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Ctexli (chenodiol) to treat adults with ...
PMLiVE6h
Recce’s topical gel shows promise in acute bacterial skin and skin structure infections
Recce Pharmaceuticals has shared positive data from a mid-stage study of its RECCE 327 topical gel (R327G) in acute bacterial ...
PMLiVE6h
NICE recommends pharmaand’s Rubraca for advanced ovarian cancer
The National Institute of Health and Care Excellence (NICE) has recommended pharmaand’s (pharma&) Rubraca (rucaparib) as a ...
PMLiVE6h
Class is the missing link in health equity strategies
In 1958, in his book Nation of Immigrants, John F Kennedy mused: ‘One of America’s characteristics has always been the lack ...